Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1333


The Transcriptome of Rhabdomyosarcoma Cells Infected with Cytolytic and Non-Cytolytic Variants of Coxsackievirus B2 Ohio-1.

Sävneby A, Luthman J, Nordenskjöld F, Andersson B, Lindberg AM.

PLoS One. 2016 Oct 19;11(10):e0164548. doi: 10.1371/journal.pone.0164548.


Coronary flow reserve in patients with resistant hypertension.

Völz S, Svedlund S, Andersson B, Li-Ming G, Rundqvist B.

Clin Res Cardiol. 2016 Oct 17.


Item Response Theory Observed-Score Kernel Equating.

Andersson B, Wiberg M.

Psychometrika. 2016 Oct 14.


Acute biliary pancreatitis - focus on recurrence rate and costs when current guidelines are not complied.

Ragnarsson T, Andersson R, Ansari D, Persson U, Andersson B.

Scand J Gastroenterol. 2016 Oct 4:1-19.


Cell-specific nitrogen- and carbon-fixation of cyanobacteria in a temperate marine system (baltic sea).

Klawonn I, Nahar N, Walve J, Andersson B, Olofsson M, Svedén BJ, Littmann S, Whitehouse MJ, Kuypers M, Ploug H.

Environ Microbiol. 2016 Oct 1. doi: 10.1111/1462-2920.13557.


Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy.

Valdez BC, Li Y, Murray D, Brammer JE, Liu Y, Hosing C, Nieto Y, Champlin RE, Andersson BS.

Oncotarget. 2016 Aug 24. doi: 10.18632/oncotarget.11561. [Epub ahead of print]


Virome characterisation from Guthrie cards in children who later developed acute lymphoblastic leukaemia.

Bogdanovic G, Pou C, Barrientos-Somarribas M, Bjerkner A, Honkaniemi E, Allander T, Andersson B, Gustafsson B.

Br J Cancer. 2016 Oct 11;115(8):1008-1014. doi: 10.1038/bjc.2016.261.


Pretransplantion minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia.

Oran B, Jorgensen JL, Marin D, Wang S, Ahmed S, Alousi AM, Andersson BS, Bashir Q, Bassett R Jr, Lyons G, Chen J, Rezvani K, Popat U, Kebriaei P, Patel K, Rondon G, Shpall EJ, Champlin RE.

Haematologica. 2016 Aug 18. pii: haematol.2016.144253. [Epub ahead of print]


Analysis of the Influence of HLA-A Matching Relative to HLA-B and -DR Matching on Heart Transplant Outcomes.

Ansari D, Bućin D, Höglund P, Ohlsson M, Andersson B, Nilsson J.

Transplant Direct. 2015 Oct 19;1(9):e38. doi: 10.1097/TXD.0000000000000545. eCollection 2015 Oct.


Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.

Alatrash G, Thall PF, Valdez BC, Fox PS, Ning J, Garber HR, Janbey S, Worth LL, Popat U, Hosing C, Alousi AM, Kebriaei P, Shpall EJ, Jones RB, de Lima M, Rondon G, Chen J, Champlin RE, Andersson BS.

Biol Blood Marrow Transplant. 2016 Oct;22(10):1792-800. doi: 10.1016/j.bbmt.2016.06.023. Epub 2016 Jul 1.


Autophagy induction targeting mTORC1 enhances Mycobacterium tuberculosis replication in HIV co-infected human macrophages.

Andersson AM, Andersson B, Lorell C, Raffetseder J, Larsson M, Blomgran R.

Sci Rep. 2016 Jun 15;6:28171. doi: 10.1038/srep28171.


Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells.

Valdez BC, Brammer JE, Li Y, Murray D, Teo EC, Liu Y, Hosing C, Nieto Y, Champlin RE, Andersson BS.

Leuk Res. 2016 Aug;47:100-8. doi: 10.1016/j.leukres.2016.05.019. Epub 2016 May 27.


Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.

Sekine T, Marin D, Cao K, Li L, Mehta P, Shaim H, Sobieski C, Jones R, Oran B, Hosing C, Rondon G, Alsuliman A, Paust S, Andersson B, Popat U, Kebriaei P, Muftuoglu M, Basar R, Kondo K, Nieto Y, Shah N, Olson A, Alousi A, Liu E, Sarvaria A, Parmar S, Armstrong-James D, Imahashi N, Molldrem J, Champlin R, Shpall EJ, Rezvani K.

Blood. 2016 Jul 14;128(2):297-312. doi: 10.1182/blood-2016-03-706317. Epub 2016 May 31.


Pancreatic cancer: yesterday, today and tomorrow.

Ansari D, Tingstedt B, Andersson B, Holmquist F, Sturesson C, Williamsson C, Sasor A, Borg D, Bauden M, Andersson R.

Future Oncol. 2016 Aug;12(16):1929-46. doi: 10.2217/fon-2016-0010. Epub 2016 Jun 1.


Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.

Nieto Y, Valdez BC, Thall PF, Jones RB, Wei W, Myers A, Hosing C, Ahmed S, Popat U, Shpall EJ, Qazilbash M, Gulbis A, Anderlini P, Shah N, Bashir Q, Alousi A, Oki Y, Fanale M, Dabaja B, Pinnix C, Champlin R, Andersson BS.

Cancer. 2016 Sep 1;122(17):2680-8. doi: 10.1002/cncr.30100. Epub 2016 May 20.


Pretransplant conditioning with fludarabine and IV busulfan, reduced toxicity and increased safety without compromising antitumor efficacy and overall treatment effect?

Andersson BS, Valdez BC.

Bone Marrow Transplant. 2016 Jul;51(7):919-20. doi: 10.1038/bmt.2016.110. Epub 2016 Apr 25. No abstract available.


Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis.

Kotecha D, Manzano L, Krum H, Rosano G, Holmes J, Altman DG, Collins PD, Packer M, Wikstrand J, Coats AJ, Cleland JG, Kirchhof P, von Lueder TG, Rigby AS, Andersson B, Lip GY, van Veldhuisen DJ, Shibata MC, Wedel H, Böhm M, Flather MD; Beta-Blockers in Heart Failure Collaborative Group.

BMJ. 2016 Apr 20;353:i1855. doi: 10.1136/bmj.i1855. Review.


Safety of pancreatic resection in the elderly: a retrospective analysis of 556 patients.

Ansari D, Aronsson L, Fredriksson J, Andersson B, Andersson R.

Ann Gastroenterol. 2016 Apr-Jun;29(2):221-5. doi: 10.20524/aog.2016.0016.


Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD-Positive Acute Myelogenous Leukemia.

Oran B, Cortes J, Beitinjaneh A, Chen HC, de Lima M, Patel K, Ravandi F, Wang X, Brandt M, Andersson BS, Ciurea S, Santos FP, de Padua Silva L, Shpall EJ, Champlin RE, Kantarjian H, Borthakur G.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1218-26. doi: 10.1016/j.bbmt.2016.03.027. Epub 2016 Apr 4.


Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells.

Teo EC, Valdez BC, Ji J, Li Y, Liu Y, Brammer JE, Hosing C, Nieto Y, Champlin RE, Andersson BS.

Leuk Lymphoma. 2016 Nov;57(11):2644-52. doi: 10.3109/10428194.2016.1157871. Epub 2016 Mar 16.

Items per page

Supplemental Content

Loading ...
Support Center